🚨 Reminder: Join our Maternal & Newborn Health Learning Session on 19 March 2026
Speakers:
- Olayide Akanni, NGO Delegation Board member
- Patricia Asero, ICW Kenya
- Jeff Smith, Unitaid
- Dr. Yogesh Rajkotia, ThinkWell
- Bahati Haule, AFROCAB
Register here: us06web.zoom.us/meeting/regi...
📢 Save the date: Maternal & Newborn Health Learning Session
Join the NGO & Communities Delegations for a civil society learning session on the MNH landscape, access gaps, and opportunities for action.
🗓 19 March 2026
🕒 15:00-16:30 CET
🔗 Register: us06web.zoom.us/meeting/regi...
A new UK Government review says Unitaid is a critical enabler of global health, helping bridge the gap between breakthrough products and the people who need them most. For the second year running, the UK's FCDO awarded Unitaid an A+ rating.
Read more: unitaid.org/news-blog/un...
We’re launching a new funding opportunity to tackle systemic barriers limiting access to life-saving maternal and newborn health products in low- and middle-income countries. Deadline to apply: 20 March 2026.
Learn more: unitaid.org/news-blog/un...
More good news in the rollout of #lenacapavir for #HIV #PrEP: @unitaid.bsky.social will give funding to SA + Zambia to broaden access, unitaid.org/news-blog/un...
Another step forward in rolling #LEN out with speed, scale and equity. For the latest on LEN: avac.org/lenacapavir/
🔇New Unitaid Call for Proposals:
Accelerating Cervical Cancer Elimination through Secondary Prevention in Low- and Middle-Income Countries
Deadline: 9 April 2026 (12:00 CET)
unitaid.org/call-for-pro...
Join the NGO & Communities Delegation to the @unitaid.bsky.social Board at #ICASA2025 to discuss Unitaid & the future of HIV access!
Date: Thursday 4 December 2025
Time: 15:00-16:00 (Accra)
@unitaidcommunities.bsky.social
@unitaidngos.bsky.social
@unitaid.bsky.social
28.11.2025 18:03 — 👍 0 🔁 0 💬 1 📌 0
As malaria continues to affect millions, new science offers hope. Our new report shows how genetically modified mosquitoes can move from research to responsible use, helping countries prepare for equitable, evidence-based deployment. More from @mggalvin.bsky.social: www.euronews.com/health/2025/...
11.11.2025 13:05 — 👍 3 🔁 4 💬 0 📌 0
🔈NGO & Communities Delegations Celebrate Unitaid’s Success in Accelerating Affordable Access to Long-Acting Lenacapavir for PrEP at a price of US$40 per person per year.
See statement:
unitaidngodelegation.org/2025/09/24/u...
@unitaid.bsky.social
@unitaidcommunities.bsky.social
CHAI
WITS RHI
@unitaid.bsky.social @unitaidcommunities.bsky.social
24.09.2025 20:53 — 👍 1 🔁 0 💬 0 📌 0
@unitaid.bsky.social @unitaidcommunities.bsky.social
24.09.2025 20:35 — 👍 2 🔁 0 💬 1 📌 0
🔈Unitaid NGO & Communities Delegations Celebrate Unitaid’s Success in Accelerating Affordable Access to Long-Acting Lenacapavir for PrEP at a price of US$40 per person per year - just two years after first approvals.
unitaidngodelegation.org/2025/09/24/u...
Register to join our co-ed Florence Anam alongside @unitaid.bsky.social and @kelinkenya.bsky.social leaders on tomorrow's webinar focusing on Community-Driven Regional Manufacturing for HIV Response.
Date: 15 July 2025
Time: 2-3:30
Register here: us06web.zoom.us/webinar/regi...
🔊Reminder to sign up below for our upcoming webinar with
@unitaidcommunities.bsky.social @oneillinstitute.bsky.social
'The Road to Long-Acting Antiretroviral Therapy'
Thursday 17 April
3-4:30pm SAST & CET
💻 georgetown.zoom.us/webinar/regi...
